Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates

被引：27

作者：

Harrigan, PR ^{[1
]}

Larder, BA ^{[1
]}

机构：

[1] Virco UK Ltd, Cambridge, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2002年 / 46卷 / 03期

关键词：

D O I：

10.1128/AAC.46.3.909-912.2002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The phenomenon of cross-resistance to, antiretroviral agents used to treat human immunodeficiency virus type 1 infection is well known but so far has been only qualitatively described. Here, we quantitate the degree of cross-resistance among all commonly, prescribed antiretroviral agents in almost 5,000 clinically derived recombinant isolates collected in the United States since January 2000.

引用

收藏

页码：909 / 912

页数：4

相关论文

共 9 条

[1] Nonnucleoside reverse transcriptase inhibitor resistance [J].

Deeks, SG .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S25-S33

[2] Antiretroviral drug resistance in HIV-1 [J].

George J. Hanna ;

Richard T. D’Aquila .

Current Infectious Disease Reports, 1999, 1 (3) :289-297

[3] Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. -: J Antimicrob Chemother 1998; 42:269-270 [J].

Vahaboglu, H ;

Saribas, S ;

Akbal, H ;

Ozturk, R ;

Yucel, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :269-270

[4] Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy [J].

Kaplan, JE ;

Hanson, D ;

Dworkin, MS ;

Frederick, T ;

Bertolli, J ;

Lindegren, ML ;

Holmberg, S ;

Jones, JL .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S5-S14

[5] Nucleoside reverse transcriptase inhibitor resistance [J].

Loveday, C .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S10-S24

[6] Resistance to protease inhibitors [J].

Miller, V .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S34-S50

[7] Natural history of HIV infection in the era of combination antiretroviral therapy [J].

Moore, RD ;

Chaisson, RE .

AIDS, 1999, 13 (14) :1933-1942

[8] Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection [J].

Palella, FJ ;

Delaney, KM ;

Moorman, AC ;

Loveless, MO ;

Fuhrer, J ;

Satten, GA ;

Aschman, DJ ;

Holmberg, SD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :853-860

[9] Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance [J].

Swanstrom, R ;

Erona, J .

PHARMACOLOGY & THERAPEUTICS, 2000, 86 (02) :145-170